DE2242375C3 - 1,4-Disubstituierte 6-Nitro-2(1 H(-chinazolinone - Google Patents

1,4-Disubstituierte 6-Nitro-2(1 H(-chinazolinone

Info

Publication number
DE2242375C3
DE2242375C3 DE2242375A DE2242375A DE2242375C3 DE 2242375 C3 DE2242375 C3 DE 2242375C3 DE 2242375 A DE2242375 A DE 2242375A DE 2242375 A DE2242375 A DE 2242375A DE 2242375 C3 DE2242375 C3 DE 2242375C3
Authority
DE
Germany
Prior art keywords
general formula
compound
meaning given
group
acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
DE2242375A
Other languages
German (de)
English (en)
Other versions
DE2242375B2 (de
DE2242375A1 (de
Inventor
Shigeho Inaba
Kikuo Ikeda Ishizumi
Toshiaki Komatsu
Masao Koshiba
Kazuo Kobe Mori
Shigeaki Takarazuka Morooka
Hiroshi Noguchi
Hisao Nishinomiya Yamamoto
Michihiro Nishinomiya Yamamoto
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sumitomo Chemical Co Ltd
Original Assignee
Sumitomo Chemical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP6766971A external-priority patent/JPS4832891A/ja
Priority claimed from JP8118171A external-priority patent/JPS5013272B2/ja
Priority claimed from JP1822072A external-priority patent/JPS4887012A/ja
Priority claimed from JP2035672A external-priority patent/JPS4918882A/ja
Application filed by Sumitomo Chemical Co Ltd filed Critical Sumitomo Chemical Co Ltd
Publication of DE2242375A1 publication Critical patent/DE2242375A1/de
Publication of DE2242375B2 publication Critical patent/DE2242375B2/de
Application granted granted Critical
Publication of DE2242375C3 publication Critical patent/DE2242375C3/de
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE2242375A 1971-09-01 1972-08-29 1,4-Disubstituierte 6-Nitro-2(1 H(-chinazolinone Expired DE2242375C3 (de)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP6766971A JPS4832891A (enExample) 1971-09-01 1971-09-01
JP8118171A JPS5013272B2 (enExample) 1971-10-14 1971-10-14
JP1822072A JPS4887012A (enExample) 1972-02-21 1972-02-21
JP2035672A JPS4918882A (enExample) 1972-02-28 1972-02-28

Publications (3)

Publication Number Publication Date
DE2242375A1 DE2242375A1 (de) 1973-03-15
DE2242375B2 DE2242375B2 (de) 1974-09-05
DE2242375C3 true DE2242375C3 (de) 1975-04-30

Family

ID=27456920

Family Applications (1)

Application Number Title Priority Date Filing Date
DE2242375A Expired DE2242375C3 (de) 1971-09-01 1972-08-29 1,4-Disubstituierte 6-Nitro-2(1 H(-chinazolinone

Country Status (10)

Country Link
AR (1) AR207543A1 (enExample)
AU (1) AU452198B2 (enExample)
BE (1) BE788213A (enExample)
CA (1) CA1006161A (enExample)
CH (1) CH579562A5 (enExample)
DE (1) DE2242375C3 (enExample)
FR (1) FR2151036B1 (enExample)
GB (1) GB1394191A (enExample)
NL (1) NL7211867A (enExample)
SE (1) SE395453B (enExample)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4071516A (en) 1976-08-20 1978-01-31 Sandoz, Inc. 4-(Acyloxyphenyl)-quinazolin-2(1H)-ones

Also Published As

Publication number Publication date
FR2151036B1 (enExample) 1975-10-17
CH579562A5 (enExample) 1976-09-15
FR2151036A1 (enExample) 1973-04-13
SE395453B (sv) 1977-08-15
GB1394191A (en) 1975-05-14
DE2242375B2 (de) 1974-09-05
AU452198B2 (en) 1974-08-29
AU4587772A (en) 1974-02-28
BE788213A (fr) 1973-02-28
AR207543A1 (es) 1976-10-15
NL7211867A (enExample) 1973-03-05
CA1006161A (en) 1977-03-01
DE2242375A1 (de) 1973-03-15

Similar Documents

Publication Publication Date Title
DE2634288C3 (enExample)
CH635823A5 (de) Verfahren zur herstellung von neuen 1-amidin-3-substituierten-phenylharnstoffen.
DE2713389C2 (enExample)
EP0028765B1 (de) Alkylharnstoffderivate zur Behandlung von Erkrankungen des Fettstoffwechsels; Verfahren zu deren Herstellung, deren Verwendung in Arzneimitteln zur Behandlung von Fettstoffwechselstörungen, diese enthaltende Arzneimittel, Verfahren zur Herstellung der Arzneimittel sowie einige Alkylharnstoffverbindungen
DE1802394A1 (de) Aminoguanidine,Verfahren zu ihrer Herstellung und ihre Verwendung
EP0189473A1 (de) Neue dopamin-derivate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel.
DE2363348C3 (de) Substituierte 5 (6)-Phenoxy-benzimidazol-2-carbaminsäuremethylester, deren Herstellung und diese enthaltende Anthelminthika
DE69021347T2 (de) Isatinderivate, ihre Herstellung und Verwendung.
DE2551945A1 (de) Substituierte phenylaethanolamine und verfahren zu deren herstellung
EP0557879A1 (de) 4-Amino-2-ureido-pyrimidin-5-carbonsäureamide, Verfahren zu deren Herstellung, diese Verbindungen enthaltende Arzneimittel und deren Verwendung
DE3141387C2 (enExample)
EP0000784B1 (de) 4-Hydroxy-2-Benzimidazolinon-derivate, Verfahren zu deren Herstellung sowie diese Verbindungen enthaltende Arzneimittel
DE3320394A1 (de) Optisch aktive n-arylierte oxazolidinon-(2)-derivate, deren verwendung als spezifische und reversible inhibitoren von monoaminooxydase des b-typs sowie verfahren zu deren herstellung
CH642668A5 (de) 2,6-diaminonebularine, verfahren zu deren herstellung und sie enthaltende pharmazeutische praeparate.
DE2242375C3 (de) 1,4-Disubstituierte 6-Nitro-2(1 H(-chinazolinone
EP0006217B1 (de) Substituierte Aminoalkansäuren, ihre Verwendung und Herstellung und sie enthaltende Arzneimittel
DE3879378T2 (de) Amid-verbindungen.
DE2457309A1 (de) 2-phenylhydrazinothiazolin- beziehungsweise 2-phenylhydrazinothiazininderivate sowie ihre verwendung und verfahren zur herstellung derselben
DE3337925C2 (de) N-(6-Aminopurinyl)-4-hydroxy-2-methyl-2H-1,2-benzothiazin-3-carboxamid-1,1-dioxid, Verfahren zu dessen Herstellung und seine Verwendung
DE3152942T1 (de) Heterocyclisch substituierte amidinoharnstoffe und ihre therapeutische anwendung
DE2738498C3 (de) H2-Chloräthyl)-l-nitroso-3-(2-acetamido-2desoxy- ß -D-glucopyranosyl)- harnstoffe, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
CH630895A5 (de) Verfahren zur herstellung neuer oximaetherverbindungen.
EP0006458B1 (de) Neue N1-Benzoyl-N2-phenyl-1,3-diaminopropan-2-ole und ihre Salze; Verfahren zu deren Herstellung und diese Verbindungen enthaltende Arzneimittel
EP0124630A1 (de) Pyrimidin-Thioalkylpyridin-Derivate, Verfahren zu ihrer Herstellung und diese Verbindung enthaltende Arzneimittel
EP0002836B1 (de) Acylhydrocarbylaminoalkansäuren, ihre Herstellung und Verwendung sowie sie enthaltende Arzneimittel

Legal Events

Date Code Title Description
C3 Grant after two publication steps (3rd publication)
E77 Valid patent as to the heymanns-index 1977
8339 Ceased/non-payment of the annual fee